Can Probiotic Supplements Improve Outcomes in Rheumatoid Arthritis?

Area of Science:

• Microbiome research
• Immunology
• Rheumatology

Background:

• The human microbiota is increasingly linked to the development and progression of rheumatoid arthritis (RA).
• Specific microbial communities in the oral cavity and gut may influence immune responses relevant to RA pathogenesis, including citrullination and systemic inflammation.

Purpose of the Study:

• To review the scientific and historical context of the human microbiota's role in rheumatoid arthritis (RA).
• To evaluate the existing clinical trial evidence for probiotic use in managing RA.
• To identify potential future research directions for probiotics in RA treatment.

Main Methods:

• Literature review of studies investigating the microbiota-RA connection.
• Analysis of clinical trial data on probiotic interventions for RA patients.
• Synthesis of findings to assess the current evidence base.

Main Results:

• Laboratory and clinical data suggest a link between oral and gut microbiota and RA risk factors like citrullination and immune dysregulation.
• Existing clinical trials are generally small, short-term, and report varied, often clinically insignificant, endpoints.
• No consistent or robust evidence of probiotic efficacy on patient-reported outcomes or laboratory markers in RA has emerged.

Conclusions:

• While theoretical rationale exists for probiotics as adjunctive RA therapy, current clinical evidence is insufficient.
• Improvements in clinical trial design are necessary to adequately assess the therapeutic potential of probiotics in autoimmune diseases like RA.
• Further investigation into specific probiotic strains and targeted delivery may be warranted.